4
Clinical Trials associated with Cord blood cell(Cord Blood Registry)Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal
Autologous human umbilical cord blood (hUCB) stored at Cord Blood Registry will be given to children who have suffered from a Perinatal Arterial Ischemic Stroke. The aim is to determine if hUCB infusion is safe, if late functional outcome is improved, if hUCB treatment improves physiologic response in the child's SSEP & EEG, and the effect of hUCB infusion in altering anatomic findings on MRI.
/ Unknown statusPhase 1/2IIT Study Safety and Efficacy of of AUTOLOGOUS Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) for the Patient With Duchenne Muscular Dystrophy. It is Self Funded (Patients' Own Funding) Clinical Trial
This Study is single arm, single center trial to check the safety and efficacy of BMMNC (100 million per dose) for the patient with Duchenne Muscular Dystrophy,
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
To determine if autologous human umbilical cord blood infusion in children with acquired hearing loss is safe, feasible, improves inner ear function, audition and language development.
100 Clinical Results associated with Cord blood cell(Cord Blood Registry)
100 Translational Medicine associated with Cord blood cell(Cord Blood Registry)
100 Patents (Medical) associated with Cord blood cell(Cord Blood Registry)
100 Deals associated with Cord blood cell(Cord Blood Registry)